Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease

Chikkathur N. Madhavarao, Peethambaran Arun, John R. Moffett, Sylvia Szucs, Sankar Surendran, Reuben Matalon, James Garbern, Diana Hristova, Anne Johnson, Wei Jiang, M. A Aryan Namboodiri

Research output: Contribution to journalArticle

128 Citations (Scopus)

Abstract

Canavan's disease (CD) is a fatal, hereditary disorder of CNS development that has been linked to mutations in the gene for the enzyme aspartoacylase (ASPA) (EC 3.5.1.15). ASPA acts to hydrolyze N-acetylaspartate (NAA) into L-aspartate and acetate, but the connection between ASPA deficiency and the failure of proper CNS development is unclear. We hypothesize that one function of ASPA is to provide acetate for the increased lipid synthesis that occurs during postnatal CNS myelination. The gene encoding ASPA has been inactivated in the mouse model of CD, and here we show significant decreases in the synthesis of six classes of myelin-associated lipids, as well as reduced acetate levels, in the brains of these mice at the time of peak postnatal CNS myelination. Analysis of the lipid content of white matter from a human CD patient showed decreased cerebroside and sulfatide relative to normal white matter. These results demonstrate that myelin lipid synthesis is significantly compromised in CD and provide direct evidence that defective myelin synthesis, resulting from a deficiency of NAA-derived acetate, is involved in the pathogenesis of CD.

Original languageEnglish (US)
Pages (from-to)5221-5226
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume102
Issue number14
DOIs
StatePublished - Apr 5 2005

Fingerprint

Canavan Disease
Myelin Sheath
Acetates
Lipids
Brain
Cerebrosides
Sulfoglycosphingolipids
Aspartic Acid
Genes
N-acetylaspartate
Mutation
aspartoacylase
Enzymes

Keywords

  • Acetyl CoA
  • Aspartoacylase
  • Leukodystrophy
  • Oligodendrocytes

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. / Madhavarao, Chikkathur N.; Arun, Peethambaran; Moffett, John R.; Szucs, Sylvia; Surendran, Sankar; Matalon, Reuben; Garbern, James; Hristova, Diana; Johnson, Anne; Jiang, Wei; Namboodiri, M. A Aryan.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 14, 05.04.2005, p. 5221-5226.

Research output: Contribution to journalArticle

Madhavarao, CN, Arun, P, Moffett, JR, Szucs, S, Surendran, S, Matalon, R, Garbern, J, Hristova, D, Johnson, A, Jiang, W & Namboodiri, MAA 2005, 'Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease', Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 14, pp. 5221-5226. https://doi.org/10.1073/pnas.0409184102
Madhavarao, Chikkathur N. ; Arun, Peethambaran ; Moffett, John R. ; Szucs, Sylvia ; Surendran, Sankar ; Matalon, Reuben ; Garbern, James ; Hristova, Diana ; Johnson, Anne ; Jiang, Wei ; Namboodiri, M. A Aryan. / Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. In: Proceedings of the National Academy of Sciences of the United States of America. 2005 ; Vol. 102, No. 14. pp. 5221-5226.
@article{5c38cbb5ec2b48f8b8d95a28b8cb4e5e,
title = "Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease",
abstract = "Canavan's disease (CD) is a fatal, hereditary disorder of CNS development that has been linked to mutations in the gene for the enzyme aspartoacylase (ASPA) (EC 3.5.1.15). ASPA acts to hydrolyze N-acetylaspartate (NAA) into L-aspartate and acetate, but the connection between ASPA deficiency and the failure of proper CNS development is unclear. We hypothesize that one function of ASPA is to provide acetate for the increased lipid synthesis that occurs during postnatal CNS myelination. The gene encoding ASPA has been inactivated in the mouse model of CD, and here we show significant decreases in the synthesis of six classes of myelin-associated lipids, as well as reduced acetate levels, in the brains of these mice at the time of peak postnatal CNS myelination. Analysis of the lipid content of white matter from a human CD patient showed decreased cerebroside and sulfatide relative to normal white matter. These results demonstrate that myelin lipid synthesis is significantly compromised in CD and provide direct evidence that defective myelin synthesis, resulting from a deficiency of NAA-derived acetate, is involved in the pathogenesis of CD.",
keywords = "Acetyl CoA, Aspartoacylase, Leukodystrophy, Oligodendrocytes",
author = "Madhavarao, {Chikkathur N.} and Peethambaran Arun and Moffett, {John R.} and Sylvia Szucs and Sankar Surendran and Reuben Matalon and James Garbern and Diana Hristova and Anne Johnson and Wei Jiang and Namboodiri, {M. A Aryan}",
year = "2005",
month = "4",
day = "5",
doi = "10.1073/pnas.0409184102",
language = "English (US)",
volume = "102",
pages = "5221--5226",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "14",

}

TY - JOUR

T1 - Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease

AU - Madhavarao, Chikkathur N.

AU - Arun, Peethambaran

AU - Moffett, John R.

AU - Szucs, Sylvia

AU - Surendran, Sankar

AU - Matalon, Reuben

AU - Garbern, James

AU - Hristova, Diana

AU - Johnson, Anne

AU - Jiang, Wei

AU - Namboodiri, M. A Aryan

PY - 2005/4/5

Y1 - 2005/4/5

N2 - Canavan's disease (CD) is a fatal, hereditary disorder of CNS development that has been linked to mutations in the gene for the enzyme aspartoacylase (ASPA) (EC 3.5.1.15). ASPA acts to hydrolyze N-acetylaspartate (NAA) into L-aspartate and acetate, but the connection between ASPA deficiency and the failure of proper CNS development is unclear. We hypothesize that one function of ASPA is to provide acetate for the increased lipid synthesis that occurs during postnatal CNS myelination. The gene encoding ASPA has been inactivated in the mouse model of CD, and here we show significant decreases in the synthesis of six classes of myelin-associated lipids, as well as reduced acetate levels, in the brains of these mice at the time of peak postnatal CNS myelination. Analysis of the lipid content of white matter from a human CD patient showed decreased cerebroside and sulfatide relative to normal white matter. These results demonstrate that myelin lipid synthesis is significantly compromised in CD and provide direct evidence that defective myelin synthesis, resulting from a deficiency of NAA-derived acetate, is involved in the pathogenesis of CD.

AB - Canavan's disease (CD) is a fatal, hereditary disorder of CNS development that has been linked to mutations in the gene for the enzyme aspartoacylase (ASPA) (EC 3.5.1.15). ASPA acts to hydrolyze N-acetylaspartate (NAA) into L-aspartate and acetate, but the connection between ASPA deficiency and the failure of proper CNS development is unclear. We hypothesize that one function of ASPA is to provide acetate for the increased lipid synthesis that occurs during postnatal CNS myelination. The gene encoding ASPA has been inactivated in the mouse model of CD, and here we show significant decreases in the synthesis of six classes of myelin-associated lipids, as well as reduced acetate levels, in the brains of these mice at the time of peak postnatal CNS myelination. Analysis of the lipid content of white matter from a human CD patient showed decreased cerebroside and sulfatide relative to normal white matter. These results demonstrate that myelin lipid synthesis is significantly compromised in CD and provide direct evidence that defective myelin synthesis, resulting from a deficiency of NAA-derived acetate, is involved in the pathogenesis of CD.

KW - Acetyl CoA

KW - Aspartoacylase

KW - Leukodystrophy

KW - Oligodendrocytes

UR - http://www.scopus.com/inward/record.url?scp=20144389547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144389547&partnerID=8YFLogxK

U2 - 10.1073/pnas.0409184102

DO - 10.1073/pnas.0409184102

M3 - Article

VL - 102

SP - 5221

EP - 5226

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 14

ER -